Fish oil-enriched nutrition combined with systemic chemotherapy for gastrointestinal cancer patients with cancer cachexia
Abstract Despite recent advances in chemotherapy for gastrointestinal cancer, a crucial factor related to poor prognosis is reduced tolerance to chemotherapy induced by cancer cachexia. Fish oil (FO)-derived eicosapentaenoic acid (EPA) modulates inflammation in patients with various malignancies; ho...
Guardado en:
Autores principales: | Yumiko Shirai, Yoshinaga Okugawa, Asahi Hishida, Aki Ogawa, Kyoko Okamoto, Miki Shintani, Yuki Morimoto, Ryutaro Nishikawa, Takeshi Yokoe, Koji Tanaka, Hisashi Urata, Yuji Toiyama, Yasuhiro Inoue, Motoyoshi Tanaka, Yasuhiko Mohri, Ajay Goel, Masato Kusunoki, Donald C. McMillan, Chikao Miki |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/99229cdd1bcb4200bd32214a7014fbb3 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Activation of the Complement System in Patients with Cancer Cachexia
por: Min Deng, et al.
Publicado: (2021) -
Amelioration of muscle wasting by gintonin in cancer cachexia
por: Yoseph Toni Wijaya, et al.
Publicado: (2021) -
Towards Drug Repurposing in Cancer Cachexia: Potential Targets and Candidates
por: Joana M. O. Santos, et al.
Publicado: (2021) -
Mitochondrial Dysfunction in Cancer Cachexia: Impact on Muscle Health and Regeneration
por: Marc Beltrà, et al.
Publicado: (2021) -
Lipocalin 2 mediates appetite suppression during pancreatic cancer cachexia
por: Brennan Olson, et al.
Publicado: (2021)